TORONTO -- (MARKET WIRE) -- December 05, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it made two poster presentations of clinical data at the International Diabetes Federation 19th World Diabetes Congress (www.idf2006.org) in Cape Town, South Africa, December 3 - 7, 2006.
